ACIP Recommendations for Inactivated Japanese Encephalitis Virus Vaccine

Japanese encephalitis vaccine was available in the United States on an investigational basis from 1983 through 1987. The inactivated vaccine (JE-VAX) was licensed on December 10, 1992, to meet the needs of U.S. travelers to Asia and the military. This dataset appears to contain the Advisory Committee on Immunization Practices (ACIP) recommendations for its use.

Use Cases

• Analyzing the timeline of vaccine approval and distribution based on the described availability from 1983-1987 and licensure in 1992.
• Studying public health policy development for travel-related diseases based on the mention of recommendations for U.S. residents traveling to Asia.
• Researching the role of advisory committees like the ACIP in shaping immunization practices based on the title and description.

Strengths

• Description provides specific historical dates: investigational availability from 1983-1987 and licensure on December 10, 1992.
• Description identifies key organizations involved: the Advisory Committee on Immunization Practices (ACIP), CDC, Biken, and Connaught Laboratories.

Limitations

• Row count, file formats, and column-level documentation are unknown, which limits suitability assessment.
• The last update date is unknown; freshness is unverified.
• The dataset's license is listed as closed, restricting access and reuse.

Provenance

Source

Advisory Committee on Immunization Practices (ACIP)

Collection Method

Likely contains official medical guidelines and recommendations.

Time Range

Mentions events from 1983 to 1992.

Geography

Primarily United States, with relevance to travel to Asia.